Dual mutations in the AML1 and FLT3 genes in patients with acute myeloblastic leukemia of the M0 subtype

被引：0
|
作者：
Matsuno, N
Osato, M
Nanri, T
Shigesada, K
Fukushima, T
Motoji, T
Kusumoto, S
Naoe, T
Ohno, R
Mitsuya, H
Ito, Y
Asou, N
机构：
[1] Kumamoto Univ, Sch Med, Kumamoto 860, Japan
[2] Natl Univ Singapore, Singapore 117548, Singapore
[3] Kyoto Univ, Kyoto, Japan
[4] Japan Adult Leukemia Study Grp, Nagoya, Aichi, Japan
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
64
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [11] Outcomes of Salvage Treatment in Patients with Acute Myeloid Leukemia (AML) with FLT3 Mutations
    Chen, Yiming
    Cortes, Jorge
    Lin, E.
    Ravandi, Farhad
    Faderl, Stefan
    Kadia, Tapan
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2009, 114 (22) : 820 - 820
  • [12] Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia
    Dicker, Frank
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    BLOOD, 2007, 110 (04) : 1308 - 1316
  • [13] FLT3 TYROSINE KINASE DOMAIN (TKD) MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Markova, J.
    Michkova, P.
    Maaloufova, J.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 550 - 550
  • [14] Molecular Characterization of FLT3 Mutations in Acute Leukemia Patients
    Ishfaq, Mariam
    Malik, Arif
    Faiz, Mariam
    Sheikh, Ishfaq Ahmad
    Asif, Muhammad
    Khan, Muhammad Nasrullah
    Qureshi, Muhammad Saeed
    Zahid, Sara
    Manan, Abdul
    Arooj, Mahwish
    Qazi, Mahmood Husain
    Chaudhary, Adeel
    Alqahtani, Mohammed Hussain
    Rasool, Mahmood
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) : 4581 - 4585
  • [15] Midostaurin for Patients With Acute Myeloid Leukemia and FLT3 Mutations
    Levis, Mark James
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (06) : 323 - 325
  • [16] High incidence of biallelic point mutations in the runt domain of the AML1 gene in M0 AML.
    Preudhomme, C
    Warot-Loze, D
    Roumier, C
    Desnoulez, L
    Grardel-Duflos, N
    Lai, JL
    Denis, C
    Bauters, F
    Cosson, A
    Fenaux, P
    BLOOD, 1999, 94 (10) : 595A - 595A
  • [17] Prognostic significance of FLT3/ITD mutation in AML1/ETO-associated acute myeloid leukemia
    Kim, Yeo-Kyeoung
    Kim, Hee-Nam
    Lee, Il-Kwon
    Bang, Soo-Mee
    Jo, Deog-Yeon
    Won, Jong-Ho
    Yim, Chang-Yeol
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    BLOOD, 2007, 110 (11) : 1023A - 1023A
  • [18] Effect of vorinostat use on survival in patients with acute myeloid leukemia (AML) with FLT3 ITD mutations
    Chae, Young Kwang
    Dimou, Anastasios
    Takahashi, Koichi
    Benton, Christopher Brent
    Jabbour, Elias
    Ravandi, Farhad
    Borthakur, Gautam
    Cortes, Jorge E.
    Kadia, Tapan M.
    Thomas, Deborah A.
    Wierda, William G.
    Daver, Naval Guastad
    Dinardo, Courtney Denton
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [19] GILTERITINIB IN THE TREATMENT OF ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH RETREADING OR REFRACTORY FLT3 MUTATIONS (R / R): A RETROSPECTIVE EFFECTIVENESS AND SAFETY STUDY
    Quintela, D.
    Morgades, M.
    Cervera, M.
    Diaz-Beya, M.
    Arnan, M.
    Garrido, A.
    Coll, R.
    Tormo, M.
    Merchan, B.
    Sampol, A.
    Huguet, M.
    De la Fuente, C.
    Esteve, J.
    Sierra, J.
    Ribera, J. M.
    Vives, S.
    HAEMATOLOGICA, 2021, 106 (10) : 215 - 216
  • [20] THE FLT3 TYROSINE KINASE AS A THERAPEUTIC TARGET IN ACUTE MYELOBLASTIC LEUKEMIA
    Griffin, J.
    ANNALS OF ONCOLOGY, 2009, 20 : 23 - 23
12345